美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NED Davis Research 360 Dynamic Allocation Etf

19.48

0.0000

成交量：3.00

成交額：58.53

市值：253.30萬

市盈率：- -

高：19.48

開：19.48

低：19.48

收：19.48

資料載入中...

總覽公司新聞公告

2024藥企出海：做難而正確的事

国际金融报

近9000億美元軍費支出拜登簽署2025財年國防授權法案

美媒：美參議院推進《國防授權法案》，為最終通過年度國防政策法案做準備

美全面禁止從科技到大蒜等中國商品法案充斥着同中國對抗

美國眾議院通過2025財年“國防授權法案”，全面禁止進口從激光雷達到大蒜等中國商品

《生物安全法案》“搭便車”NDAA失敗，國內CXO板塊迎反彈

每日经济新闻

藥明系迎大利好！下一個催化劑是？

【A股收評】三大指數震盪調整，機器人概念捲土重來！

美生物安全法案“生變”，CRO概念大舉反攻，藥明系嗨了！

美生物安全法案未納入NDAA，CXO巨頭藥明康德飆升逾7.5%！醫療ETF（512170）漲超1%衝擊三連陽

港股概念追蹤|生物安全法案未被列入NDAA最新版本機構看好CXO板塊底部機會（附概念股）

港股異動 | CRO概念股集體高開生物安全法案未被列入美參眾兩院最終版NDAA

美國防法案未納入生物安全“黑名單”，美媒：意味着與中國有關的公司獲得喘息之機

短線要防“假突破”，交易面盯緊三個變量！

剛剛，利好來了！央行出手，重要數據將發佈，證監會最新發聲……影響一週市場的十大消息

生物醫藥傳來重磅利好！美國NDAA最新版本顯示生物安全法案未被列入其中，影響多大？生物醫藥能否迎來大爆發

美國2025財年國防授權法案最終協議文本公佈，生物安全法案未被列入

美國2025財年國防授權法案最終協議文本公佈生物安全法案未被列入

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NDAA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NDAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NDAA\",,,,,undefined,":{"symbol":"NDAA","market":"US","secType":"STK","nameCN":"NED Davis Research 360 Dynamic Allocation Etf","latestPrice":19.4844,"timestamp":1747425600000,"preClose":19.4844,"halted":0,"volume":3,"delay":0,"floatShares":130000,"shares":130000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"05-16 16:00:00 EDT","open":19.4844,"high":19.4844,"low":19.4844,"amount":58.53,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":19.4844,"sharesOutstanding":130000,"nav":19.48,"aum":2532400,"bidAskSpread":0,"volumeRatio":0.003446690978475932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NDAA\",,,,,undefined,":{"symbol":"NDAA","floatShares":130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.003446690978475932,"shares":130000,"dividePrice":0,"high":19.4844,"amplitude":0,"preClose":19.4844,"low":19.4844,"week52Low":17.52,"pbRate":"--","week52High":20.41,"institutionHeld":0,"latestPrice":19.4844,"eps":0,"divideRate":0,"volume":3,"delay":0,"ttmEps":0,"open":19.4844,"prevYearClose":19.6666,"prevWeekClose":18.5686,"prevMonthClose":18.5686,"prevQuarterClose":19.401,"fiveDayClose":18.5686,"twentyDayClose":18.3266,"sixtyDayClose":19.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NDAA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495054976","title":"2024藥企出海：做難而正確的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2495054976","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495054976?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 20:41","pubTimestamp":1735562466,"startTime":"0","endTime":"0","summary":"2024年，出海依然是生物医药产业的关键词。ADC、双抗药物合作交易火爆，出海数量再创新高；交易金额上限不断突破，多家药企凭借出海扭亏为盈。海外市场为生物医药产业带来了新的增量和发展方向，但走好出海之路绝非易事。近年来，创新药海外合作数量上升的同时，也有部分合作半路终止。此外，还有企业受地缘政治等因素影响，割舍或是调整海外业务。不过，好在各方都没有放弃，而是积极探索出新的道路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282962268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282962268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NDAA","PML","02162","BK1583","BK1515","BK4532","LU1829250122.USD","BK4007","BK1587","BK4080","BK1574","BK4588","ADC","BK1161","09939","BK4231","GSK","GSK.UK","BMS","BK4585"],"gpt_icon":0},{"id":"2493727494","title":"近9000億美元軍費支出 拜登簽署2025財年國防授權法案","url":"https://stock-news.laohu8.com/highlight/detail?id=2493727494","media":"环球时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493727494?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 13:51","pubTimestamp":1735019460,"startTime":"0","endTime":"0","summary":"当地时间23日，美国总统拜登签署2025财年国防授权法案，将美国军费支出提升至约8950亿美元，较上一财年增长1%。2025财年国防授权法案将提升现役军人工资，增加在亚太的军事支出，并授权美军与以色列军队拓展联合军事演习等。桑德斯认为，美国的国防体系已成为少数大型国防承包商牟利的工具，而不是服务于国家需要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-24/doc-ineapwes8469507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"gpt_icon":0},{"id":"2492860614","title":"美媒：美參議院推進《國防授權法案》，為最終通過年度國防政策法案做準備","url":"https://stock-news.laohu8.com/highlight/detail?id=2492860614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492860614?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 11:47","pubTimestamp":1734407273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["NDAA"],"gpt_icon":0},{"id":"2490071840","title":"美全面禁止從科技到大蒜等中國商品 法案充斥着同中國對抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2490071840","media":"映象网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490071840?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 11:19","pubTimestamp":1733973540,"startTime":"0","endTime":"0","summary":"从激光导航技术到大蒜，美国国会众议院已经通过了一项包含禁止诸多中国进口商品的法案，并极有可能在今年年底成为正式法律。报道指出，“国防授权法案”为美国国防部设定了最高预算并指导政策方向，可谓是一项“必须通过”的法案，因为该法案的颁布是军人按时领取薪资和福利的必要条件。而与往年一样，2025财年的“国防授权法案”充斥着“同中国竞争和对抗”的相关内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-12/doc-inczekkt3179903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"gpt_icon":0},{"id":"2490845309","title":"美國眾議院通過2025財年“國防授權法案”，全面禁止進口從激光雷達到大蒜等中國商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2490845309","media":"观察者网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490845309?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 09:07","pubTimestamp":1733965620,"startTime":"0","endTime":"0","summary":"而与往年一样，2025财年的“国防授权法案”充斥着“同中国竞争和对抗”的相关内容。去年12月，美国总统拜登曾将“2024财年国防授权法案”签署成法，该法案包含涉华消极条款。对此，中国外交部发言人毛宁回应指出，美方执意通过并签署包含涉华消极内容的“2024财年国防授权法案”，中方对此表示强烈不满和坚决反对，已向美方提出严正交涉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-12/doc-inczeeax0016643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AEI","BK4582","FDD","BK4024","NDAA","BK4563"],"gpt_icon":0},{"id":"2490301723","title":"《生物安全法案》“搭便車”NDAA失敗，國內CXO板塊迎反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2490301723","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490301723?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 19:22","pubTimestamp":1733743341,"startTime":"0","endTime":"0","summary":"每经记者：许立波&nbsp;&nbsp;&nbsp;&nbsp;每经编辑：杨夏当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案（以下简称“NDAA”）最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，《生物安全法案》未被列入其中，意味着《生物安全法案》通过“夹带”进NDAA进而实现立法的...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OVeLbzmbNy8zvfEv4R_rJMi0rf7KWPkL8gZp0PEHwB5W4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241209A08E2000","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241209A08E2000","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["NDAA","CXO"],"gpt_icon":0},{"id":"2490710665","title":"藥明系迎大利好！下一個催化劑是？","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710665","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490710665?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 16:16","pubTimestamp":1733732183,"startTime":"0","endTime":"0","summary":"周末消息称，美国生物安全法案未被纳入NDAA，多家机构表示，这可能是国内医药板块的关键节点。","market":"hk","thumbnail":"https://img.jin10.com/news/24/12/Qzge3Cc2IR7IBRzKIVp1Z.png/lite","type":0,"news_type":0,"thumbnails":["https://img.jin10.com/news/24/12/Qzge3Cc2IR7IBRzKIVp1Z.png/lite"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://xnews.jin10.com/webapp/details.html?id=155494&type=news&data_type=0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"xnew_highlight","symbols":["NDAA"],"gpt_icon":0},{"id":"2490146827","title":"【A股收評】三大指數震盪調整，機器人概念捲土重來！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490146827","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490146827?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 15:22","pubTimestamp":1733728930,"startTime":"0","endTime":"0","summary":"12月9日，三大指数集体调整，截至收盘，沪指跌0.05%，深成指跌0.55%，创业板跌0.81%，科创50指数跌1.09%，两市超2000只个股上涨，沪深两市今日成交额约1.63万亿元。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/752e3c68-7dfe-4a74-b97c-1a04beb480c3.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/752e3c68-7dfe-4a74-b97c-1a04beb480c3.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67569aa253243c0b5baf20c0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["NDAA"],"gpt_icon":0},{"id":"2490718823","title":"美生物安全法案“生變”，CRO概念大舉反攻，藥明系嗨了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490718823","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490718823?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 12:10","pubTimestamp":1733717419,"startTime":"0","endTime":"0","summary":"行业悲观预期或好转","market":"sg","thumbnail":"https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1449943","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU2242644610.SGD","LU2488822045.USD","LU0823426308.USD","LU1242518931.SGD","02268","LU0320764599.SGD","LU0856984785.SGD","BK0081","LU0456842615.SGD","LU0456846285.SGD","BK1583","LU0516422366.SGD","LU0052750758.USD","BK0102","LU1046422090.SGD","LU0359201612.USD","02359","BK0042","BK1576","301201","LU0051755006.USD","BK0028","LU0348825331.USD","BK0077","300149","LU0307460666.USD","LU0572944931.SGD","NDAA","SG9999002562.SGD","SG9999014674.SGD","BK1141","LU1688375341.USD","LU1880383366.USD","LU2039709279.SGD","LU1997245177.USD","LU1794554557.SGD","LU2045819591.USD","LU0456827905.SGD","LU0327786744.USD","BK0216","LU0823426480.USD","000710","LU0359202008.SGD","LU0348735423.USD","LU0819121731.USD","603259","BK0086","LU0043850808.USD","BK1521"],"gpt_icon":1},{"id":"2490959507","title":"美生物安全法案未納入NDAA，CXO巨頭藥明康德飆升逾7.5%！醫療ETF（512170）漲超1%衝擊三連陽","url":"https://stock-news.laohu8.com/highlight/detail?id=2490959507","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490959507?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 10:49","pubTimestamp":1733712540,"startTime":"0","endTime":"0","summary":"海外利空解除，9日早盘，巨头药明康德跳空高开逾8%后维持高位，现涨超7.5%，领涨50只中证医疗成份股！九州药业、凯莱英、康龙化成等CXO概念股纷纷跟涨。　　267亿体量顶流医疗ETF高开近2%，现涨逾1%。　　消息面上，美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-09/doc-incyvnxt2953829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","LU0320764599.SGD","NDAA","LU2488822045.USD","02359","BK1141","159828","LU2125910500.SGD","LU2242644610.SGD","512170","LU1997245094.SGD","603259","BK1576","LU2045819591.USD","BK1583","LU0052750758.USD","LU1046422090.SGD","LU0708995583.HKD","BK0216","LU0456842615.SGD","LU1997245177.USD"],"gpt_icon":0},{"id":"2490901767","title":"港股概念追蹤|生物安全法案未被列入NDAA最新版本   機構看好CXO板塊底部機會（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2490901767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490901767?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 09:29","pubTimestamp":1733707775,"startTime":"0","endTime":"0","summary":"美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。当地时间12月5日， 专注于生物制药行业的美国新闻媒体Endpoints报道，消息人士称，立法者正在考虑对针对生物安全法案的立法进行妥协，该立法将增加行政部门的审查，而不是直接禁止生物制药公司与中国公司合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456827905.SGD","BK1141","BK1583","NDAA","LU0516423174.USD","BK1610","LU0051755006.USD","LU0181495838.USD","LU1242518857.USD","YANG","LU0823426480.USD","LU0039217434.USD","07226","LU0516422440.USD","HSTECH","LU0588546209.SGD","LU2039709279.SGD","LU0979878070.USD","CXO","LU0140636845.USD","LU0417516902.SGD","LU1242518931.SGD","LU2045819591.USD","LU0417516738.SGD","LU0359201612.USD","02269","LU0708995583.HKD","LU1880383366.USD","LU0307460666.USD","BK1576","HSCEI","LU1794554557.SGD","06821","LU0348825331.USD","LU0043850808.USD","LU2242644610.SGD","LU2125910500.SGD","BK1521","LU0052750758.USD","LU0348735423.USD","LU1720050803.USD","LU0516423091.SGD","LU0516422366.SGD","LU0359202008.SGD","BK1191","LU0572944931.SGD","LU0856984785.SGD","02359","BK1589","LU1046422090.SGD"],"gpt_icon":1},{"id":"2490762502","title":"港股異動 | CRO概念股集體高開 生物安全法案未被列入美參眾兩院最終版NDAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2490762502","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490762502?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 09:23","pubTimestamp":1733707405,"startTime":"0","endTime":"0","summary":"消息面上，当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。按照流程，该版本要获得美国总统签字之后才能生效。招银国国际认为，这意味着生物安全法案试图通过加入NDAA的立法路径失败。生物安全法案仍可以推进单独立法，但考虑到仅剩两周窗口期，该行认为单独立法的成功率极低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0307460666.USD","LU0417516738.SGD","LU0320764599.SGD","02269","LU0516422952.EUR","LU0708995583.HKD","BK1141","03759","LU0140636845.USD","HK0000320264.USD","06127","LU0516423091.SGD","LU1242518931.SGD","LU1720050803.USD","HK0000306685.HKD","BK1589","LU0348825331.USD","LU1688375341.USD","LU0039217434.USD","SG9999002463.SGD","LU0823426480.USD","LU2045819591.USD","LU0516423174.USD","LU2242644610.SGD","BK1610","LU0856984785.SGD","LU0417516902.SGD","NDAA","LU0979878070.USD","LU1046422090.SGD","LU0572944931.SGD","LU0516422366.SGD","02359","LU0327786744.USD","LU0359201612.USD","LU1794554557.SGD","LU0456846285.SGD","HK0000320223.HKD","HK0000306701.USD","LU0588546209.SGD","LU2125910500.SGD","LU0348735423.USD","BK1521","LU0516422440.USD","LU0823426308.USD","BK1583","LU0181495838.USD","LU0052750758.USD","IE00B0JY6N72.USD","01548"],"gpt_icon":1},{"id":"2490968798","title":"美國防法案未納入生物安全“黑名單”，美媒：意味着與中國有關的公司獲得喘息之機","url":"https://stock-news.laohu8.com/highlight/detail?id=2490968798","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490968798?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 06:36","pubTimestamp":1733697360,"startTime":"0","endTime":"0","summary":"7日，美国国会参众两院军事委员会公布了年度国防授权法案最终协议文本，《生物安全法案》未被列入其中。彭博社7日称，这意味着与中国有关联的生物技术公司暂时不会被列入禁止签订合同的黑名单中，这让这些公司获得了喘息之机。《生物安全法案》将影响5家中资企业，包括药明康德等生物科技企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-09/doc-incyvakc6272988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA"],"gpt_icon":0},{"id":"2489738003","title":"短線要防“假突破”，交易面盯緊三個變量！","url":"https://stock-news.laohu8.com/highlight/detail?id=2489738003","media":"钱眼","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489738003?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 19:09","pubTimestamp":1733656140,"startTime":"0","endTime":"0","summary":"NDAA最新版本显示，生物安全法案未被列入其中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-12-08/doc-incytywr6842943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NDAA","159982"],"gpt_icon":0},{"id":"2489780219","title":"剛剛，利好來了！央行出手，重要數據將發佈，證監會最新發聲……影響一週市場的十大消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2489780219","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489780219?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 18:24","pubTimestamp":1733653440,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　重要数据将发布。　　12月9日，国家统计局将公布11月全国CPI和PPI。12月14日，将公布流通领域重要生产资料市场价格变动情况。　　12月10日，德国将公布11月CPI，澳洲联储将公布12月利率决议；12月11日，美国将公布11月CPI，加拿大央行将公布12月利率决议；12月13日，美国将公布11月PPI数据、12月7日初请失业金人数，欧洲央行将公布12月利率决议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/quanshang/qsyj/2024-12-08/doc-incytywm3676979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IAU","GCmain","159934","MGCmain","DUST","NDAA","SGCmain","518880","NUGT","SGUmain","GLD","GDX"],"gpt_icon":0},{"id":"2489854907","title":"生物醫藥傳來重磅利好！美國NDAA最新版本顯示生物安全法案未被列入其中，影響多大？生物醫藥能否迎來大爆發","url":"https://stock-news.laohu8.com/highlight/detail?id=2489854907","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489854907?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 14:42","pubTimestamp":1733640120,"startTime":"0","endTime":"0","summary":"　　据报道，美国当地时间12月7日，美国国会参众两院军事委员会公布的2025财年国防授权法案 最终协议文本显示，生物安全法案未被列入其中。按照流程，该版本要获得美国总统签字之后才能生效。　　12月6日，券商中国曾报道，美国立法者正考虑对生物安全法案进行更改，妥协版本内容包括增加对相关公司行政审查环节，而非自动禁止生物制药公司与中国公司合作。药明康德和药明生物因此大涨，CRO板块集体飙升。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-08/doc-incytuqt6927173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","NDAA","161726"],"gpt_icon":0},{"id":"2489204512","title":"美國2025財年國防授權法案最終協議文本公佈，生物安全法案未被列入","url":"https://stock-news.laohu8.com/highlight/detail?id=2489204512","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489204512?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 11:34","pubTimestamp":1733628863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1997245094.SGD","LU0359202008.SGD","LU0456846285.SGD","LU1242518931.SGD","LU0456827905.SGD","LU0572944931.SGD","LU0051755006.USD","LU0052750758.USD","HSCEI","07226","HSTECH","SG9999002562.SGD","LU0348825331.USD","LU0327786744.USD","BK0216","LU0588546209.SGD","LU1720050803.USD","LU2125910500.SGD","BK1141","LU0320764599.SGD","BK1576","LU0326950275.SGD","02269","LU0856984785.SGD","LU2242644610.SGD","LU0516423091.SGD","LU1046422090.SGD","LU2045819591.USD","BK1521","LU0307460666.USD","YANG","LU1997245177.USD","02359","LU1242518857.USD","IE00B0JY6N72.USD","SG9999002463.SGD","NDAA","LU1880383366.USD","603259","LU0417516738.SGD","LU0348735423.USD","LU0417516902.SGD","LU0819121731.USD","LU0140636845.USD","BK1610","LU2488822045.USD","BK1583","LU0708995583.HKD","LU0516422440.USD","LU0359201612.USD"],"gpt_icon":0},{"id":"2489204521","title":"美國2025財年國防授權法案最終協議文本公佈 生物安全法案未被列入","url":"https://stock-news.laohu8.com/highlight/detail?id=2489204521","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489204521?lang=zh_tw&edition=fundamental","pubTime":"2024-12-08 11:30","pubTimestamp":1733628604,"startTime":"0","endTime":"0","summary":"美国当地时间2024年12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案（NDAA）最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。按照流程，该版本要获得美国总统签字之后才能生效。公开资料显示：NDAA是美国国会每年通过的一项法案，用于授权国防预算和军事人员的规模，以及确定国防政策和优先事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412083262105445.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412083262105445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0823426480.USD","LU0516422952.EUR","LU0516423174.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0348825331.USD","LU0516422366.SGD","LU0417516738.SGD","LU0043850808.USD","LU2039709279.SGD","BK1576","BK1589","LU0320764599.SGD","LU0456846285.SGD","LU0572944931.SGD","LU0051755006.USD","LU0823426308.USD","LU0516423091.SGD","LU0359201612.USD","LU0359202008.SGD","BK1610","LU0516422440.USD","LU1880383366.USD","NDAA","LU0456827905.SGD","LU0819121731.USD","LU1242518931.SGD","LU0307460666.USD","SG9999002562.SGD","LU0979878070.USD","LU0140636845.USD","LU0417516902.SGD","LU0039217434.USD","LU1720050803.USD","SG9999002463.SGD","LU0348735423.USD","BK1141","BK1521","LU0326950275.SGD","LU0181495838.USD","LU0856984785.SGD","LU1794554557.SGD","LU0588546209.SGD","LU0052750758.USD","LU0327786744.USD","LU1688375341.USD","LU1242518857.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NDAA\",params:#limit:5,,,undefined,":[{"date":"2024-12-26","symbol":"NDAA","amount":0.16273,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-26","defaultRemindTime":1735223400000,"name":"NED Davis Research 360 Dynamic Allocation Etf","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-26","currency":"USD","dateTimestamp":1735189200000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NDAA\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-26","recordDate":"2024-12-26","paymentDate":"2024-12-30","value":0.16273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NDAA\",market:\"US\",delay:false,,,undefined,":{}}}